Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph R Arron

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Current Opinion in Rheumatology|August 22, 2021
Biomarkers in systemic sclerosis: mechanistic insights into pathogenesis and treatmentJoseph R Arron
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|October 28, 2003
TRAF6, a molecular bridge spanning adaptive immunity, innate immunity and osteoimmunologyHao Wu, Joseph R Arron
Thorax|November 30, 2014
Asthma biomarkers: what constitutes a 'gold standard'?Joseph R Arron, Kenji Izuhara
Nature Reviews. Drug Discovery|July 16, 2016
Reducing the risk of failure: biomarker-guided trial designMichael J Townsend, Joseph R Arron
Expert Opinion on Therapeutic Targets|April 1, 2020
Beyond type 2 cytokines in asthma - new insights from old clinical trialsDavid F Choy, Joseph R Arron
The Journal of Allergy and Clinical Immunology|December 20, 2015
ReplyYvonne J Huang, Joseph R Arron, Homer Boushey
Current Protocols in Immunology|April 25, 2008
TRAF-mediated TNFR-family signalingJoseph R Arron, Matthew C Walsh, Yongwon Choi
Nature Reviews. Rheumatology|October 3, 2009
Promising bone-related therapeutic targets for rheumatoid arthritisYongwon Choi, Joseph R Arron, Michael J Townsend
Nature Medicine|February 7, 2009
Breaking into bone biology: target practiceYongwon Choi, Matthew C Walsh, Joseph R Arron
Advances in Pharmacology (San Diego, Calif.)|February 26, 2013
Redefining approaches to asthma: developing targeted biologic therapiesJoseph R Arron, Heleen Scheerens, John G Matthews
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Current Opinion in Rheumatology|August 22, 2021
Biomarkers in systemic sclerosis: mechanistic insights into pathogenesis and treatmentJoseph R Arron
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|October 28, 2003
TRAF6, a molecular bridge spanning adaptive immunity, innate immunity and osteoimmunologyHao Wu, Joseph R Arron
Thorax|November 30, 2014
Asthma biomarkers: what constitutes a 'gold standard'?Joseph R Arron, Kenji Izuhara
Nature Reviews. Drug Discovery|July 16, 2016
Reducing the risk of failure: biomarker-guided trial designMichael J Townsend, Joseph R Arron
Expert Opinion on Therapeutic Targets|April 1, 2020
Beyond type 2 cytokines in asthma - new insights from old clinical trialsDavid F Choy, Joseph R Arron
The Journal of Allergy and Clinical Immunology|December 20, 2015
ReplyYvonne J Huang, Joseph R Arron, Homer Boushey
Current Protocols in Immunology|April 25, 2008
TRAF-mediated TNFR-family signalingJoseph R Arron, Matthew C Walsh, Yongwon Choi
Nature Reviews. Rheumatology|October 3, 2009
Promising bone-related therapeutic targets for rheumatoid arthritisYongwon Choi, Joseph R Arron, Michael J Townsend
Nature Medicine|February 7, 2009
Breaking into bone biology: target practiceYongwon Choi, Matthew C Walsh, Joseph R Arron
Advances in Pharmacology (San Diego, Calif.)|February 26, 2013
Redefining approaches to asthma: developing targeted biologic therapiesJoseph R Arron, Heleen Scheerens, John G Matthews
Pageof 10